Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Clearmind Medicine Inc (NQ: CMND ) 1.660 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Clearmind Medicine Inc < Previous 1 2 3 4 5 6 Next > Why Clearmind Stock Is Climbing Higher Tuesday December 05, 2023 Clearmind Medicine Inc (NYSE: CMND) shares are trading higher Tuesday after the company announced results in its cocaine addiction treatment. Via Benzinga Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More December 05, 2023 Defense Dept. Funds Ketamine Study For PTSD Treatment Via Benzinga Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session November 30, 2023 Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results. Via Benzinga Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket November 30, 2023 Shares of Salesforce, Inc. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 30, 2023 It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning! Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday November 29, 2023 Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning! Via InvestorPlace Why Clearmind Medicine Stock Is Moving Today November 28, 2023 Clearmind Medicine Inc. (NASDAQ: CMND) shares are trading higher on Tuesday after the company announced results from its weight loss and metabol Via Benzinga EXCLUSIVE: Clearmind Medicine's Psychedelic-Based Treatment Shows Encouraging Preclinical Activity In Obesity, Metabolic Disorders November 28, 2023 Clearmind Medicine Inc (NASDAQ: CMND) has released results from its pre-clinical trial of the combination therapy. Via Benzinga Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket November 27, 2023 Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter. Via Benzinga Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice November 21, 2023 Clearmind Medicine Inc. (NASDAQ: CMND) is set to conduct a 1-for-30 reverse share split of its issued and outstanding ordin Via Benzinga Why BSQUARE Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket October 12, 2023 Gainers OpGen, Inc. (NASDAQ: OPGN) shares rose 432% to $1.79 in pre-market trading. Opgen said on Oct. 6, unit Curetis GMBH received payment of 750,000 euros related to the sale of certain Unyvero A50... Via Benzinga Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session October 12, 2023 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday October 12, 2023 Pre-market stock movers are a hot topic among traders on Thursday and we're offering all of the latest coverage this morning! Via InvestorPlace Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session October 11, 2023 Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in... Via Benzinga Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More September 18, 2023 Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next Via Benzinga Exposures Product Safety Psychedelics Capital Moves: Beckley Waves Raises $3.3M, Clearmind's $2.25M Public Offering September 15, 2023 Beckley Waves: $3.3 Million Round To Expand Safe & Legal Access To Psychedelic Therapies Via Benzinga Nasdaq Surges 100 Points; First Wave BioPharma Shares Spike Higher September 14, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.93% to 34,898.47 while the NASDAQ rose 0.75% to 13,917.44.... Via Benzinga Topics Stocks Exposures US Equities Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session September 14, 2023 Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi. Via Benzinga Crude Oil Rises Sharply; BIOLASE Shares Plunge September 14, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.61% to 34,784.94 while the NASDAQ rose 0.71% to 13,911.78. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Clearmind Medicine Stock Is Getting Hammered Today September 14, 2023 Clearmind Medicine Inc (NASDAQ: CMND) shares are trading lower by 53% to $0.18 Thursday morning after the company announced pricing of a $2.25 million public offering. The offering is expected to close... Via Benzinga Dow Jumps Over 200 Points; US Producer Prices Rise In August September 14, 2023 U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.71% to 34,820.58 while the NASDAQ rose 0.27% to 13,849.49. The S&P... Via Benzinga Topics Stocks Exposures US Equities Why Novo Integrated Sciences Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket September 14, 2023 Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 43.3% to $1.29 in pre-market trading. Via Benzinga Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More September 11, 2023 Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Nasdaq Grants SpiSparc, Ltd. Extension To Maintain Listing: +600% Bid Price Surge Needed September 07, 2023 Specialty clinical-stage biopharma company SciSparc Ltd. (NASDAQ: SPRC) has received a Nasdaq notice granting the company an additional 180-day compliance period until March 4 to regain compliance with... Via Benzinga Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program September 06, 2023 Israeli psychedelics biotech Clearmind Medicine (NASDAQ: CMND) has inked a research agreement with Johns Hopkins University School of Medicine (JHU) to conduct the first-in-human Phase I/IIa clinical... Via Benzinga EXCLUSIVE: Clearmind Medicine Files US Patent Application For Dyskinesia Treatment, Strengthening Its IP Portfolio August 01, 2023 Clearmind Medicine Inc (NASDAQ: CMND) has announced the filing of a provisional patent application for the treatment of Dyskinesia with the United States Patent and Trademark Office (USPTO) as part of... Via Benzinga Exclusive: Clearmind And SciSparc To Conduct Study Evaluating Psychedelics And CannAmide Based Drug For Treatment Of Obesity And Metabolic Syndrome June 16, 2023 Clearmind Medicine Inc. (NASDAQ: CMND) (CSE:CMND) (FSE:CWY) announced that as part of the company's ongoing collaboration with SciSparc Ltd. Via Benzinga MEAI Compound's First Clinical Trial In US, Clearmind Enters NASDAQ Compliance Period May 22, 2023 Clearmind Medicine Inc. (NASDAQ: CMND), an Israel-based biotech company advancing the clinical stage for an MEAI-based compound targeting Alcohol Use Disorder (AUD,) has selected Yale School of... Via Benzinga Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket May 19, 2023 Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of... Via Benzinga Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More May 15, 2023 Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.